Reportlinker Adds Growth Hormone Deficiency (GHD) - Pipeline Analysis and Market Forecasts to 2016
NEW YORK, May 27 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Growth Hormone Deficiency (GHD) - Pipeline Analysis and Market Forecasts to 2016
Growth Hormone Deficiency (GHD) - Pipeline Analysis and Market Forecasts to 2016
Summary
GlobalData, the industry analysis specialist's new report, "Growth Hormone Deficiency (GHD) - Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global growth hormone deficiency market. The report identifies the key trends shaping and driving the global growth hormone deficiency market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global growth hormone deficiency sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.
Scope
The Scope of the report includes:
- Annualized global growth hormone deficiency revenues data from 2001 to 2009, forecast forward for 7 years to 2016.
- Geographic markets covered in this report include the US (United States), the UK (United Kingdom), Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.
- Analysis of the current and future market competition in the global growth hormone deficiency market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for the future market associated with growth hormone deficiency.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global growth hormone deficiency market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global growth hormone deficiency market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What's the next big thing in the global growth hormone deficiency market landscape? – Identify, understand and capitalize.
1 Table of contents 3
1.1 List of Tables6
1.2 List of Figures7
2 Introduction and Overview 8
2.1 Disease Overview: Renal Failure 8
2.1.1 Signs and Symptoms 10
2.1.2 Pathophysiology of Renal Failure 10
2.2 Global Prevalence of Renal Failure 12
2.2.1 US Prevalence 12
2.2.2 Europe Prevalence 13
2.3 Renal Failure: Device Based Treatment Modalities 13
2.3.1 Peritoneal Dialysis 13
2.3.2 Hemodialysis 14
3 Global Renal Dialysis Equipment Market : Market Characterization 16
3.1 Global Renal Dialysis Equipment Market, Revenue ($m), Historic, 2002–2009 16
3.2 Global Renal Dialysis Equipment Market, Revenue Forecasts ($m), 2009–2016 17
3.3 Renal Dialysis Equipment, Key Market Trends 18
3.3.1 Different Countries Have Different Usage Patterns for Type of Dialysis Modality Used 18
3.3.2 Peritoneal Dialysis Is Expected To Gain Preference in the US over the Next Few Years 18
3.3.3 Deviation in the Role of Risk Factors for Renal Failure in the US and Europe 18
3.4 Renal Dialysis Equipment, Market Dynamics 18
3.4.1 Market Drivers 18
3.4.2 Market Restraints 24
3.5 Renal Dialysis Equipment Market: Opportunities and Unmet Need 24
3.5.1 Poor Quality of Life of Patients Receiving Hemodialysis 24
3.5.2 Lack of Resources to Perform HD 25
3.5.3 Lack of Effective Home Dialysis Treatment 25
4 Global Hemodialysis Equipment Market : Market Characterization 26
4.1 Global Hemodialysis Equipment Market, Revenue ($m), Historic, 2002–2009 26
4.2 Global Hemodialysis Machines Market, Revenue ($m), Forecasts, 2009–2016 27
4.3 Hemodialysis Machines Market, Market Dynamics 27
4.3.1 Market Drivers 27
4.3.2 Market Restraints 28
5 Global Peritoneal Dialysis Solutions Market : Market Characterization 29
5.1 Global Peritoneal Dialysis Solutions Market, Revenue ($m), Historic, 2002–2009 29
5.2 Global Peritoneal Dialysis Solutions Market, Revenue ($m), Forecasts, 2009–2016 30
5.3 Peritoneal Dialysis Solutions, Market Dynamics 30
5.3.1 Market Drivers 30
5.3.2 Market Restraints 31
6 Global Continuous Renal Replacement Therapy Market : Market Characterization 32
6.1 Global Continuous Renal Replacement Therapy Market, Revenue ($m), Historic, 2002–2009 32
6.2 Global Continuous Renal Replacement Therapy Market, Revenue ($m), Forecasts, 2009–2016 33
6.3 Continuous Renal Replacement Therapy, Market Dynamics 33
6.3.1 Market Drivers 33
6.3.2 Market Restraints 33
7 Global Dialysis Accessories Market : Market Characterization 34
7.1 Global Dialysis Accessories Market, Revenue ($m), Historic, 2002–2009 34
7.2 Global Dialysis Accessories Market, Revenue ($m), Forecasts, 2009–2016 35
7.3 Dialysis Accessories, Market Dynamics 35
7.3.1 Market Drivers 35
7.3.2 Market Restraints 36
8 Global Renal Dialysis Equipment Market: Cross-Country Market Analysis and Forecasts 37
8.1 Global Renal Dialysis Equipment Market: Cross-Country Analysis 37
8.2 Revenue, By Country, Historic and Forecasts, 2002–2009 38
8.2.1 Renal Dialysis Equipment Market, US, Revenue ($m), Historic, 2002–2009 38
8.2.2 Renal Dialysis Equipment Market, US, Revenue ($m), Forecasts, 2009–2016 39
8.2.3 Renal Dialysis Equipment Market, Canada, Revenue ($m), Historic, 2002–2009 40
8.2.4 Renal Dialysis Equipment Market, Canada, Revenue ($m), Forecasts, 2009–2016 41
8.2.5 Renal Dialysis Equipment Market, Germany, Revenue ($m), Historic, 2002–2009 42
8.2.6 Renal Dialysis Equipment Market, Germany, Revenue ($m), Forecasts, 2009–2016 43
8.2.7 Renal Dialysis Equipment Market, UK, Revenue ($m), Historic, 2002–2009 44
8.2.8 Renal Dialysis Equipment Market, UK, Revenue ($m), Forecasts, 2009–2016 45
8.2.9 Renal Dialysis Equipment Market, France, Revenue ($m), Historic, 2002–2009 46
8.2.10 Renal Dialysis Equipment Market, France, Revenue ($m), Forecasts, 2009–2016 47
8.2.11 Renal Dialysis Equipment Market, Italy, Revenue ($m), Historic, 2002–2009 48
8.2.12 Renal Dialysis Equipment Market, Italy, Revenue ($m), Forecasts, 2009–2016 49
8.2.13 Renal Dialysis Equipment Market, Spain, Revenue ($m), Historic, 2002–2009 50
8.2.14 Renal Dialysis Equipment Market, Spain, Revenue ($m), Forecasts, 2009–2016 51
8.2.15 Renal Dialysis Equipment Market, Japan, Revenue ($m), Historic, 2002–2009 52
8.2.16 Renal Dialysis Equipment Market, Japan, Revenue ($m), Forecasts, 2009–2016 53
8.2.17 Renal Dialysis Equipment Market, China, Revenue ($m), Historic, 2002–2009 54
8.2.18 Renal Dialysis Equipment Market, China, Revenue ($m), Forecasts, 2009–2016 55
8.2.19 Renal Dialysis Equipment Market, Australia, Revenue ($m), Historic, 2002–2009 56
8.2.20 Renal Dialysis Equipment Market, Australia, Revenue ($m), Forecasts, 2009–2016 57
8.2.21 Renal Dialysis Equipment Market, India, Revenue ($m), Historic, 2002–2009 58
8.2.22 Renal Dialysis Equipment Market, India, Revenue ($m), Forecasts, 2009–2016 59
8.2.23 Renal Dialysis Equipment Market, Brazil, Revenue ($m), Historic, 2002–2009 60
8.2.24 Renal Dialysis Equipment Market, Brazil, Revenue ($m), Forecasts, 2009–2016 61
9 Global Renal Dialysis Equipment Market: Strategic Competitive Assessment 62
9.1 Global Renal Dialysis Equipment Market, Key Company Shares (%), 2008 62
9.2 Global Renal Dialysis Equipment Market: Key Market Participants 62
9.2.1 Fresenius Medical Care AG & Co. KGaA 62
9.2.2 Baxter International Inc. 63
9.2.3 Gambro AB 65
9.2.4 B. Braun Melsungen AG 67
10 Key Renal Dialysis Equipment in the Market 68
10.1 Phoenix Dialysis System 68
10.1.1 Product Description 68
10.1.2 Features, Advantages and Benefits 68
10.2 5008 Therapy System 68
10.2.1 Product Description 68
10.2.2 Features, Advantages and Benefits 68
10.3 4008 Machine 69
10.3.1 Product Description 69
10.3.2 Features, Advantages and Benefits 69
10.4 Dialog+ 69
10.4.1 Product Description 69
10.4.2 Features, Advantages and Benefits 70
11 Global Renal Dialysis Equipment Market: Strategic Pipeline Assessment 71
11.1 Renal Dialysis Equipment: Pipeline Products Summary 71
11.2 Profiles of Promising Products under Clinical Development 72
11.2.1 HemoAccess Valve System (HVS) 72
11.2.2 AK 200 ULTRA S 72
11.2.3 AK 96 73
11.2.4 BetaSorb 73
11.2.5 OLpur H2H 74
11.2.6 XCR–6 74
11.2.7 Renal Expres 74
12 Global Renal Dialysis Equipment Market: M&A Landscape 76
12.1 Global Renal Dialysis Equipment Market: Deals Overview 76
12.2 Key Acquisitions 76
12.2.1 Asahi Kasei Kuraray Medical to Acquire Additional 53% Stake in Med-Tech 76
12.2.2 Asia Renal Care Acquires 20% Interest in Nephromed 77
12.2.3 Dialysis Corporation of America (DCA) Acquires St. Thomas More Dialysis Center 77
12.2.4 RA Group Holdings Acquires National Renal Alliance 77
13 Appendix 78
13.1 Definitions 78
13.1.1 Renal Dialysis Equipment 78
13.1.2 Continuous Renal Replacement Therapy Machines 78
13.1.3 Dialysis Accessories 78
13.1.4 Hemodialysis Machines 78
13.1.5 Peritoneal Dialysis Solutions 79
13.2 Acronyms 79
13.3 Research Methodology 80
13.4 Secondary Research 81
13.5 Primary Research 81
13.6 Models 82
13.7 Forecasts 82
13.8 Expert Panels 82
13.9 GlobalData Consulting 82
13.10 Contact Us 83
13.11 Disclaimer 83
1.1 List of Tables
Table 1: GHD Therapeutics, Global, Market Revenues ($bn), 2001-2009 6
Table 2: GHD Therapeutics, Global, Market Forecast ($bn), 2009-2016 7
Table 3: GHD Therapeutics – Most Promising Drugs Under Clinical Development, 2010 19
Table 4: GHD Therapeutics – Phase III Clinical Pipeline, 2010 24
Table 5: GHD Therapeutics – Phase II Clinical Pipeline, 2010 24
Table 6: GHD Therapeutics – Phase I Clinical Pipeline, 2010 24
Table 7: GHD Therapeutics – Preclinical Phase Pipeline, 2010 24
1.2 List of Figures
Figure 1: GHD Therapeutics, Global, Market Revenues ($bn), 2001-2009 6
Figure 2: GHD Therapeutics, Global, Market Forecast ($bn), 2009-2016 7
Figure 3: Opportunity and Unmet Need in the GHD Therapeutics Market, 2010 9
Figure 4: Strategic Competitor Assessment of the Marketed Products for GHD, 2010 11
Figure 5: Technology Trends Analytic Framework of the GHD Pipeline – 2010 18
Figure 6: Technology Trends Analytic Framework of the GHD Pipeline – Description, 2010 18
Figure 7: GHD Therapeutics Market , Clinical Pipeline by Mechanism of Action, 2010 23
Figure 8: GHD Pipeline by Phase of Clinical Development, 2010 23
Figure 9: Implications for Future Market Competition in the GHD Therapeutics Market, 2010 26
Figure 10: GHD Therapeutics Market – Clinical Pipeline by Company, Number of Molecules, 2010 28
Figure 11: GlobalData Methodology 36
Figure 12: GlobalData Market Forecasting Model 39
Companies mentioned
LG Life Sciences, Korea
Altus Pharmaceuticals, the US
Ambrx, Inc., the US
Novo Nordisk A/S, Denmark
Ipsen S.A., France
To order this report:
Drug and Medication Industry: Growth Hormone Deficiency (GHD) - Pipeline Analysis and Market Forecasts to 2016
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT: |
|
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article